I recently received a tweet regarding 3 scientists who won the 2019 Noble Prize in Physiology or Medicine. The goal of their research is to improve lung transplant survival rates by “increasing proteins that play an important part maintaining the health of blood vessels.” According to their research, the “loss of healthy blood vessels is a big contributor to failure of lung transplants.”
Further stated in the research, “scientists have increased the protein levels in animal models of lung transplant and they hope to apply the principles of science used in the animals to use on humans to either slow down or reverse the process of chronic rejection”. As a recipient of single lung transplant I am excited to share this news and hope one day this comes to fruition. What is amazing is the goal of their initial research was not to improve upon lung transplant survival rates.
If this research is successful and a medicine is regulated, would this news have any bearing on your commitment to pursue a lung transplant?
Pulmonary Fibrosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.